Trial Profile
PILOT STUDY WITH IMATINIB FOR PLEXIFORM NEUROFIBROMA IN NEUROFIBROMATOSIS TYPE I PATIENTS.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 18 Jul 2012
Price :
$35
*
At a glance
- Drugs Imatinib (Primary)
- Indications Neurofibromatosis 1; Plexiform neurofibroma
- Focus Therapeutic Use
- 21 Jun 2011 New trial record